ARX — Aroa Biosurgery Cashflow Statement
0.000.00%
Last trade - 00:00- AU$174.17m
- AU$159.55m
- NZ$84.70m
- 79
- 63
- 25
- 58
Annual cashflow statement for Aroa Biosurgery, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.134 | 0.136 | 1.17 | 1.73 | 1.51 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.01 | -11.5 | -3.77 | -7.38 | -2.57 |
| Capital Expenditures | -1.5 | -4.87 | -7.61 | -6.99 | -3.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -20 | -30 | 14.9 | 17.1 | 4 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -21.5 | -34.9 | 7.25 | 10.1 | 0.301 |
| Financing Cash Flow Items | 15.1 | -2.6 | -0.379 | -0.405 | -0.476 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 37.1 | 37.6 | -0.504 | -1.03 | -1.47 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.5 | -9.22 | 3.38 | 1.98 | -3.53 |